• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低于K/DOQI血红蛋白目标值的月数与住院和死亡风险之间的关联。

Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death.

作者信息

Ishani Areef, Solid Craig A, Weinhandl Eric D, Gilbertson David T, Foley Robert N, Collins Allan J

机构信息

Chronic Disease Research Group, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S-253, Minneapolis, MN 55404, USA.

出版信息

Nephrol Dial Transplant. 2008 May;23(5):1682-9. doi: 10.1093/ndt/gfm845. Epub 2007 Dec 8.

DOI:10.1093/ndt/gfm845
PMID:18065802
Abstract

BACKGROUND

A proportion of haemodialysis patients experience periods below target haemoglobin levels due to longer time required to reach the target or to haemoglobin level variability. We aimed to determine the consequences associated with cumulative number of months below target haemoglobin concentrations.

METHODS

We constructed an incident cohort including patients whose day 91 after dialysis initiation fell between 1 January and 31 December 2002. Haemoglobin concentration, erythropoiesis-stimulating agent dose, comorbid condition and hospitalization data were obtained from Medicare claims. Patients were classified by 0, 1, 2 or 3 months with haemoglobin concentration below the K/DOQI target (11 g/dL). Using an inverse probability weighted marginal structural model to adjust for time-varying factors associated with haemoglobin concentration, we determined the association between number of months below target and subsequent risk for hospitalization and mortality.

RESULTS

The final cohort included 54 328 patients who met criteria. Those with more months below haemoglobin target were less likely to have received intravenous iron. More months below target were associated with increased risk of hospitalization (RR 1.70, 95% CI 1.63-1.76) and mortality (RR 2.48, 95% CI 2.28-2.69).

CONCLUSIONS

Future interventions should focus on modifiable factors associated with greater time below target haemoglobin concentrations to determine whether altering the time below target can alter the risk of hospitalizations or mortality.

摘要

背景

一部分血液透析患者由于达到目标所需时间较长或血红蛋白水平波动,经历了低于目标血红蛋白水平的时期。我们旨在确定与低于目标血红蛋白浓度的累计月数相关的后果。

方法

我们构建了一个发病队列,包括透析开始后第91天在2002年1月1日至12月31日之间的患者。血红蛋白浓度、促红细胞生成素剂量、合并症和住院数据来自医疗保险理赔记录。根据血红蛋白浓度低于K/DOQI目标(11 g/dL)的0、1、2或3个月对患者进行分类。使用逆概率加权边际结构模型来调整与血红蛋白浓度相关的随时间变化的因素,我们确定了低于目标的月数与随后住院和死亡风险之间的关联。

结果

最终队列包括54328名符合标准的患者。血红蛋白低于目标的月数越多,接受静脉铁剂治疗的可能性越小。低于目标的月数越多,住院风险(RR 1.70,95% CI 1.63 - 1.76)和死亡风险(RR 2.48,95% CI 2.28 - 2.69)越高。

结论

未来的干预措施应侧重于与低于目标血红蛋白浓度的时间更长相关的可改变因素,以确定改变低于目标的时间是否可以改变住院或死亡风险。

相似文献

1
Association between number of months below K/DOQI haemoglobin target and risk of hospitalization and death.低于K/DOQI血红蛋白目标值的月数与住院和死亡风险之间的关联。
Nephrol Dial Transplant. 2008 May;23(5):1682-9. doi: 10.1093/ndt/gfm845. Epub 2007 Dec 8.
2
Time to target haemoglobin concentration (11 g/dl)--risk of hospitalization and mortality among incident dialysis patients.达到目标血红蛋白浓度(11克/分升)的时间——新发透析患者的住院风险和死亡率
Nephrol Dial Transplant. 2007 Aug;22(8):2247-55. doi: 10.1093/ndt/gfm374. Epub 2007 Jun 27.
3
Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels.血液透析患者的贫血与死亡率:预测贫血倾向评分与实际血红蛋白水平的相互作用
Nephrol Dial Transplant. 2006 Jun;21(6):1652-62. doi: 10.1093/ndt/gfk095. Epub 2006 Jan 31.
4
Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.血液透析患者的方案依从性及达到目标血红蛋白水平的能力。
Nephrol Dial Transplant. 2009 Jun;24(6):1956-62. doi: 10.1093/ndt/gfn780. Epub 2009 Jan 28.
5
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients.血红蛋白变化与促红细胞生成素给药及血液透析患者生存率之间的关联。
J Am Soc Nephrol. 2006 Apr;17(4):1181-91. doi: 10.1681/ASN.2005090997.
6
A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.一项关于贫血作为血液透析患者危险因素作用的前瞻性多中心研究:MAR研究。
Nephrol Dial Transplant. 2007 Feb;22(2):500-7. doi: 10.1093/ndt/gfl558. Epub 2006 Oct 5.
7
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.长期暴露于交通相关空气污染对荷兰呼吸道和心血管疾病死亡率的影响:荷兰长期队列空气污染研究(NLCS-AIR研究)
Res Rep Health Eff Inst. 2009 Mar(139):5-71; discussion 73-89.
8
Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.血红蛋白水平低于11 g/dL的血液透析患者中,更高剂量的促红细胞生成素α(EPO)与短期死亡风险
Pharmacoepidemiol Drug Saf. 2009 Oct;18(10):932-40. doi: 10.1002/pds.1799.
9
Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis.接受血液透析治疗的青少年实现成人血红蛋白目标与死亡率及住院率的关联。
J Am Soc Nephrol. 2006 Oct;17(10):2878-85. doi: 10.1681/ASN.2005111215. Epub 2006 Aug 30.
10
Self-reported appetite, hospitalization and death in haemodialysis patients: findings from the Hemodialysis (HEMO) Study.血液透析患者的自我报告食欲、住院情况及死亡情况:血液透析(HEMO)研究的结果
Nephrol Dial Transplant. 2005 Dec;20(12):2765-74. doi: 10.1093/ndt/gfi132. Epub 2005 Oct 4.

引用本文的文献

1
Hemoglobin stability impact on healthcare resource utilization and costs among dialysis-dependent patients with anemia of end-stage kidney disease.血红蛋白稳定性对终末期肾病贫血依赖透析患者医疗资源利用及成本的影响
BMC Nephrol. 2025 Aug 18;26(1):466. doi: 10.1186/s12882-025-04390-y.
2
Usage of the Anemia Control Model Is Associated with Reduced Hospitalization Risk in Hemodialysis.贫血控制模型的使用与血液透析患者住院风险降低相关。
Biomedicines. 2024 Sep 28;12(10):2219. doi: 10.3390/biomedicines12102219.
3
A cross-sectional study of factors influencing left ventricular myocardial work in peritoneal dialysis patients.
一项关于影响腹膜透析患者左心室心肌做功因素的横断面研究。
Heliyon. 2024 Feb 1;10(3):e25265. doi: 10.1016/j.heliyon.2024.e25265. eCollection 2024 Feb 15.
4
The Influence of Inflammation on Anemia in CKD Patients.炎症对慢性肾脏病患者贫血的影响。
Int J Mol Sci. 2020 Jan 22;21(3):725. doi: 10.3390/ijms21030725.
5
Impact of persistent anaemia on mortality in patients hospitalised with acute pulmonary embolism: an Australian retrospective observational study.澳大利亚回顾性观察研究:持续性贫血对急性肺栓塞住院患者死亡率的影响。
BMJ Open. 2019 May 1;9(4):e027112. doi: 10.1136/bmjopen-2018-027112.
6
Haemoglobin variability and all-cause mortality in haemodialysis patients: A systematic review and meta-analysis.血红蛋白变异性与血液透析患者全因死亡率:系统评价和荟萃分析。
Nephrology (Carlton). 2019 Dec;24(12):1265-1272. doi: 10.1111/nep.13560. Epub 2019 Feb 28.
7
The effect of Vitamin D administration on treatment of anemia in end-stage renal disease patients with Vitamin D deficiency on hemodialysis: A placebo-controlled, double-blind clinical trial.维生素D给药对血液透析的维生素D缺乏终末期肾病患者贫血治疗的影响:一项安慰剂对照、双盲临床试验。
J Res Med Sci. 2015 Aug;20(8):745-50. doi: 10.4103/1735-1995.168375.
8
Does erythropoietin cause hemoglobin variability--is it 'normal'?促红细胞生成素会导致血红蛋白变异性吗——这是“正常的”吗?
PLoS One. 2014 Apr 7;9(4):e92890. doi: 10.1371/journal.pone.0092890. eCollection 2014.
9
Hemoglobin variability with epoetin beta and continuous erythropoietin receptor activator in patients on peritoneal dialysis.接受培美曲塞和贝伐珠单抗治疗的非鳞非小细胞肺癌患者的生活质量分析
Perit Dial Int. 2012 Mar-Apr;32(2):177-82. doi: 10.3747/pdi.2010.00299. Epub 2011 Nov 1.
10
The effect of altitude change on anemia treatment response in hemodialysis patients.海拔变化对血液透析患者贫血治疗反应的影响。
Am J Epidemiol. 2011 Apr 1;173(7):768-77. doi: 10.1093/aje/kwq423. Epub 2011 Feb 23.